DENVER--(BUSINESS WIRE)--July 6, 2006--Corgenix Medical Corporation (OTCBB: CONX - News) has released for international sale its newest diagnostic product to be used in the fight against cardiovascular disease. The Company's AspirinWorks® Test Kit was launched at the 52nd Annual Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis, held June 28 through July 1, 2006, in Oslo, Norway.
